Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Yorvipath 168 micrograms/0.56 mL solution for injection in pre-filled pen {equilateral_black_triangle}

Active Ingredient:
palopegteriparatide
Company:  
Ascendis Pharma UK Limited See contact details
ATC code: 
H05AA05
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 05 Jul 2024

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Ascendis Pharma UK Limited
Company image
Address
Templar House, 81-87 High Holborn, London, WC1V 6DF, UK
Telephone
+44 (0)7969 628 113
Medical Information Direct Line
+44 (0)7969 628 113
Medical Information e-mail
[email protected]
WWW
www.ascendispharma.com